|8th December 2020||Bobbi Jo Brockmann||4,742||Grant/award etc.||$3.15||$14,937.30|
|12th March 2020||David Cunningham||2,000||Open or private purchase||$4.00||$8,000.00|
|11th March 2020||David Scott Tomsche||4,600||Open or private purchase||$4.28||$19,688.00|
|27th February 2020||David Scott Tomsche||5,130||Open or private purchase||$4.98||$25,547.40|
|9th December 2019||Bobbi Jo Brockmann||1,200||Grant/award etc.||$3.99||$4,788.00|
|9th December 2019||Bobbi Jo Brockmann||1,524||Grant/award etc.||$3.65||$5,562.60|
|11th March 2019||Paul R Wainman||4,269||Grant/award etc.||$4.80||$20,491.20|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.
ImmuCell Corp. was founded in 1982 and is headquartered in Portland, ME. Its products include first defense for scours, California mastitis test kit and purified nisin intramammary treatment.